Denver Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Denver Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,096	Closed	-$1.39M	–	91
2025 Q1	$1.39M	Buy	17,096 +2,480	+17%	+$222K	0.63%	23
2024 Q4	$1.32M	Sell	14,616 -163	-1%	-$15.8K	0.59%	25
2024 Q3	$1.46M	Buy	14,779 +127	+0.9%	+$12.5K	0.68%	24
2024 Q2	$1.36M	Sell	14,652 -498	-3%	-$44.6K	0.68%	23
2024 Q1	$1.44M	Buy	+15,150	New	+$1.41M	0.73%	22

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Denver Wealth Management's XBI Position: Q2 2025 in Review

Denver Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 17,096 shares — an estimated $1.39M sold.

Denver Wealth Management first reported a position in XBI in Q1 2024 and held it in 5 quarters. The position peaked at $1.46M in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Denver Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Denver Wealth Management sold 17,096 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $1.39M.
Denver Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and held it in 5 quarters.
Denver Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $1.46M in Q3 2024.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Denver Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.